BioCentury
ARTICLE | Company News

Management tracks

May 17, 2017 11:31 PM UTC

Protein therapeutics company Molecular Partners AG (SIX:MOLN) named Patrick Amstutz CEO. Amstutz had been acting CEO since the November 2016 resignation of Christian Zahnd.

Autoimmune and inflammatory disease company Akari Therapeutics plc (NASDAQ:AKTX) said CEO Gur Roshwalb will be placed on administrative leave pending investigation of an inaccurate report from Edison Investment Research Ltd. Executive Chairman Ray Prudo is leading the company in Roshwalb's absence...